Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 2/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.39 |
| ▸ | EPHB2 | P29323 | 1/20 | 0.39 |
| ▸ | FLT4 | P35916 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.39 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | G6PD | P11413 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34467644 | 0.85 | MAPT (0.57) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL21108850 | 0.85 | TGFBR1 (0.42) | LMNAGAAKMT2APTGS2AMY1A | |
| SCHEMBL28524194 | 0.84 | AMY1A (0.46) | KMT2AKDRAMY1AKDM4EMAPT | |
| SCHEMBL21450434 | 0.81 | AMY1A (0.39) | LMNAGAAKMT2APTGS2ALDH1A1 | |
| SCHEMBL24722210 | 0.80 | HSP90AA1 (0.39) | LMNAGAAKMT2AFLT1EGFR | |
| SCHEMBL22737966 | 0.79 | HSP90AA1 (0.46) | LMNAGAAKMT2AFLT1EGFR | |
| SCHEMBL20209464 | 0.79 | HSP90AA1 (0.43) | LMNAGAAKMT2AFLT1EGFR | |
| SCHEMBL1765256 | 0.78 | LMNA (0.50) | LMNAGAAKMT2AFLT1EGFR | |
| SCHEMBL1023561 | 0.76 | LMNA (0.48) | LMNAGAAKMT2AFLT1EGFR | |
| SCHEMBL22375222 | 0.75 | HSP90AA1 (0.46) | LMNAGAAKMT2AFLT1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12004419-B2 | Electroactive compounds | LG CHEM, LTD. (KR) | 2024-06-04 | — | — | US | disclosed |
| CN-114940681-A | Electroactive compounds | 株式会社LG化学 | 2022-08-26 | — | — | CN | disclosed |
| CN-110023319-B | Electroactive compounds | 株式会社LG化学 | 2022-06-17 | — | — | CN | disclosed |
| US-20220093872-A1 | Electroactive Compounds | LG CHEM, LTD. (KR) | 2022-03-24 | — | — | US | disclosed |
| US-11239426-B2 | Electroactive compounds | LG CHEM, LTD. | 2022-02-01 | — | — | US | disclosed |
| US-11239426-B2 | Electroactive compounds | LG CHEM, LTD. | 2022-02-01 | — | — | US | disclosed |
| WO-2018097937-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-31 | — | — | WO | disclosed |
| WO-2018097937-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220093872-A1 | Electroactive Compounds | KCNN3, KCNN2, HCN3 | LMNA 2804/4885GAA 2066/4885KMT2A 3397/4885 |
| US-12004419-B2 | Electroactive compounds | KCNN3, KCNN2, HCN3 | LMNA 2804/4885GAA 2066/4885KMT2A 3397/4885 |
| US-11239426-B2 | Electroactive compounds | KCNN2, HCN2, KCNN3 | LMNA 2952/4885GAA 1937/4885KMT2A 3000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.